Concepedia

Hak Choy

HC

Statistics

Publications

119

Citations

15.3K

H-Index

57

Active since

1992

Affiliations

The University of Texas Southwestern Medical Center(Current)

Vanderbilt University Medical Center

Washington University in St. Louis

The University of Texas MD Anderson Cancer Center

Vanderbilt University

Hak Choy is an author at The University of Texas Southwestern Medical Center specializing in medicine, oncology, and radiation therapy.

Publications per year

1992–2022

119

Publications

119

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki et al. · The Lancet Oncology · 2015 · 2K citations · Full text

, , +17

Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer

Puneeth Iyengar, Zabi Wardak, David E. Gerber et al. · JAMA Oncology · 2017 · 1K citations

, , +13

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial

Stephen G. Chun, Chen Hu, Hak Choy et al. · Journal of Clinical Oncology · 2016 · 748 citations · Full text

, , +17

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer

Jeffrey D. Bradley, Chen Hu, Ritsuko Komaki et al. · Journal of Clinical Oncology · 2019 · 578 citations · Full text

, , +14

Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non–Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial

Andrea Bezjak, Rebecca Paulus, Laurie E. Gaspar et al. · Journal of Clinical Oncology · 2019 · 548 citations · Full text

, , +15

1–5 of 119